IPS Biopharma AG is pioneering interventional immuno-oncology by transforming standard-of-care tumor ablations into a powerful immunotherapy against metastatic cancers. Our technology induces a tumor-specific immune response from thermally liberated tumor antigens to eliminate the cancer.
- https://immunophotonics.com
- Theresa Visarius
